Condition
Juvenile Idiopathic Arthritis (JIA) clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Juvenile Idiopathic Arthritis (JIA) clinical trials that are recruiting, at sites in 9 countries (most in Italy (3), Turkey (Türkiye) (3), France (2)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Phase 3 (1). The most active sponsors are Meyer Children's Hospital IRCCS (2), Hacettepe University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 1New in 30 days
- 9Countries
Newest Juvenile Idiopathic Arthritis (JIA) clinical trials
All recruiting trials (13)
-
Predicting the course of early-onset juvenile idiopathic arthritis using a multidimensional model
Researchers are testing a comprehensive model to predict how early-onset JIA will progress in affected children and how a small control group with iridocyclitis compares.
-
Understanding subtypes of chronic musculoskeletal pain in youth
This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.
-
Open-label extension with filgotinib for juvenile idiopathic arthritis
This long-term open-label extension sees if filgotinib stays safe and continues to control symptoms in children aged 8–17 with polyarticular or systemic juvenile idiopathic arthritis who benefited from earlier treatment.
-
Structured or video-game–based core stabilization for children with juvenile idiopathic arthritis
This study will try whether a regular structured core exercise program or a fun exergaming-based core program helps children aged 8–13 with juvenile idiopathic arthritis improve strength, reduce pain, and move better.
-
Tofacitinib in Juvenile Idiopathic Arthritis
This study looks at real-world use of tofacitinib to see if it helps control Juvenile Idiopathic Arthritis in kids over about 12 months.
-
Parents' pain catastrophizing in children with juvenile idiopathic arthritis
See if parents' worrying and negative thoughts about their child's pain are linked to treatment adherence and biopsychosocial outcomes in children with juvenile idiopathic arthritis.
-
Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases
This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.
-
Counting and classifying inflammatory cells in uveitis with OCT
This project will try to use high-resolution OCT scans to count and categorize inflammatory cells and proteins in people with anterior uveitis and related eye inflammation.
-
Dietary intervention for children with Juvenile Idiopathic Arthritis
This study is testing if a special diet without certain ingredients can help children with Juvenile Idiopathic Arthritis feel better over four weeks.
-
Exploring the link between diet and immune-related diseases in families
This study is trying to see how the diets of families with members who have conditions like Juvenile Idiopathic Arthritis, Crohn's Disease, or Ulcerative Colitis affect their health and treatment options.
-
Evaluating daily living activities in children with Juvenile Idiopathic Arthritis
This study tests how daily activities are affected in children with Juvenile Idiopathic Arthritis to see what helps improve their quality of life.
-
Investigating blood markers in juvenile idiopathic arthritis
This study is testing if certain blood markers can help predict how severe juvenile idiopathic arthritis will be in young patients as they move from pediatric to adult care.
-
National registry for children with Juvenile Idiopathic Arthritis in Canada
This study is collecting information about children in Canada with Juvenile Idiopathic Arthritis to see how the disease affects them and how different treatments work over time.
Related topics
Quick answers
How many Juvenile Idiopathic Arthritis (JIA) clinical trials are recruiting right now?
13, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Italy (3 trials), Turkey (Türkiye) (3 trials), France (2 trials), United States (2 trials), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.